Search
for
Sort by
Research 361–390 of 1000+
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome
- Adolescent Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- What every physician should know about polycystic ovary syndrome
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure